Literature DB >> 35294586

A functional liver imaging score for preoperative prediction of liver failure after hepatocellular carcinoma resection.

Ningbin Luo1, Xiangyang Huang1, Yinan Ji2, Guanqiao Jin1, Yunying Qin1, Bangde Xiang2, Danke Su3, Weizhong Tang4.   

Abstract

OBJECTIVES: Posthepatectomy liver failure (PHLF) is a challenging complication after resection to treat hepatocellular carcinoma (HCC), and it is associated with high mortality. Preoperative prediction of PHLF may improve patient subsequent and reduce such mortality. This study examined whether a functional liver imaging score (FLIS) based on preoperative gadoxetic acid-enhanced magnetic resonance imaging (MRI) could predict PHLF.
MATERIALS AND METHODS: The study included 502 patients who underwent preoperative gadoxetic acid-enhanced MRI, followed by HCC resection. Significant preoperative predictors of PHLF were identified using logistic regression analysis. The ability of FLIS to predict PHLF was evaluated using receiver operating characteristic curves, and its predictive power was compared to that of the model for end-stage liver disease (MELD) score, albumin-bilirubin (ALBI) score, and indocyanine green 15-min retention rate (ICG-R15).
RESULTS: In multivariate analysis, PHLF was independently associated with FLIS (OR 0.452, 95% CI 0.361 to 0.568, p < 0.001) and major resection (OR 1.898, 95% CI 1.057 to 3.408, p = 0.032). FLIS was associated with a higher area under the receiver operating characteristic curve (0.752) than the MELD score (0.557), ALBI score (0.609), or ICG-R15 (0.605) (all p < 0.05). Patients with FLIS ≤ 4 who underwent major resection were at 9.4-fold higher risk of PHLF than patients with lower FLIS who underwent minor resection.
CONCLUSION: FLIS is an independent predictor of PHLF, and it may perform better than the MELD score, ALBI score, and ICG-R15 clearance. We propose treating elevated FLIS and major resection as risk factors for PHLF. KEY POINTS: • A functional liver imaging score can independently predict posthepatectomy liver failure in patients with HCC. • The score may predict such failure better than MELD and ALBI scores and ICG-R15. • Patients with scores ≤ 4 who undergo major hepatic resection may be at nearly tenfold higher risk of posthepatectomy liver failure.
© 2022. The Author(s), under exclusive licence to European Society of Radiology.

Entities:  

Keywords:  Gd-EOB-DTPA; Hepatectomy; Hepatocellular carcinoma; Liver failure; Magnetic resonance imaging

Mesh:

Substances:

Year:  2022        PMID: 35294586     DOI: 10.1007/s00330-022-08656-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   7.034


  28 in total

1.  Mortality in hepatectomy: Model for End-Stage Liver Disease as a predictor of death using the National Surgical Quality Improvement Program database.

Authors:  Samuel W Ross; Ramanathan Seshadri; Amanda L Walters; Vedra A Augenstein; B Todd Heniford; David A Iannitti; John B Martinie; Dionisios Vrochides; Ryan Z Swan
Journal:  Surgery       Date:  2015-10-21       Impact factor: 3.982

2.  An ordinal model to predict the risk of symptomatic liver failure in patients with cirrhosis undergoing hepatectomy.

Authors:  Mathieu Prodeau; Elodie Drumez; Alain Duhamel; Eric Vibert; Olivier Farges; Guillaume Lassailly; Jean-Yves Mabrut; Jean Hardwigsen; Jean-Marc Régimbeau; Olivier Soubrane; René Adam; François-René Pruvot; Emmanuel Boleslawski
Journal:  J Hepatol       Date:  2019-06-14       Impact factor: 25.083

3.  Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma.

Authors:  Davide Citterio; Antonio Facciorusso; Carlo Sposito; Roberta Rota; Sherrie Bhoori; Vincenzo Mazzaferro
Journal:  JAMA Surg       Date:  2016-09-01       Impact factor: 14.766

4.  A Comparative Study of Albumin-Bilirubin Score with Child-Pugh Score, Model for End-Stage Liver Disease Score and Indocyanine Green R15 in Predicting Posthepatectomy Liver Failure for Hepatocellular Carcinoma Patients.

Authors:  Heng Zou; Xin Yang; Qing-Long Li; Qing-Xiang Zhou; Li Xiong; Yu Wen
Journal:  Dig Dis       Date:  2018-03-01       Impact factor: 2.404

5.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

Review 6.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

Review 7.  Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis.

Authors:  Annalisa Berzigotti; Maria Reig; Juan G Abraldes; Jaime Bosch; Jordi Bruix
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

8.  Relevance of liver surface nodularity for preoperative risk assessment in patients with resectable hepatocellular carcinoma.

Authors:  C Hobeika; F Cauchy; R Sartoris; A Beaufrère; T Yoh; V Vilgrain; P E Rautou; V Paradis; M Bouattour; M Ronot; O Soubrane
Journal:  Br J Surg       Date:  2020-03-02       Impact factor: 6.939

9.  Comparison of the ability of Child-Pugh score, MELD score, and ICG-R15 to assess preoperative hepatic functional reserve in patients with hepatocellular carcinoma.

Authors:  Yan-Yan Wang; Xin-Hua Zhao; Liang Ma; Jia-Zhou Ye; Fei-Xiang Wu; Juan Tang; Xue-Mei You; Bang-De Xiang; Le-Qun Li
Journal:  J Surg Oncol       Date:  2018-09       Impact factor: 3.454

10.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.